InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,432.80
(
0.58%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.56
(
1.12%
)
Bitcoin
64,334.22
(
1.60%
)
Post# of 621805
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3158
Posts 964110
Boards Moderated 196
Alias Born 09/04/2000

mick

Member Level

Re: mick post# 508690

Saturday, 04/04/2020 8:03:23 PM

Saturday, April 04, 2020 8:03:23 PM

Post# of 621805
45 mins., Diagnostics Biomerieux Launched three tests to address the COVID-19 pandemic, including the SARS-CoV-2 R-Gene test, a real-time polymerase chain reaction test that is clinically validated on one type of respiratory specimen and will be available at the end of March; the Biofire Filmarray technology developed with support of the U.S. Department of Defense; and an expanded version of its Biofire Filmarray Respiratory Panel 2, which includes SARS-CoV-2 and 21 other common respiratory pathogens and will deliver results in 45 minutes




https://www.bioworld.com/COVID19diagnostics

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up